CClinicalTrials.gg
Not yet recruitingNCT04252001YESSUpdated Sep 7, 2023

Growing up With the Young Endocrine Support System (YESS!)

An interventional study of YESS! game and Snake '97 in Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism and Growth Hormone Deficiency, sponsored by dr. Laura C. G. de Graaff-Herder. Not yet recruiting at 7 sites in 4 countries. Open to participants aged 15 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-07.

Sponsored by dr. Laura C. G. de Graaff-Herder · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
15 Years to 20 Years
Sex
All
01

Study summary

Transition from paediatric to adult endocrinology is a challenge for adolescents, families and doctors. Up to 25% of young adults with chronic endocrine disorders are lost to follow-up ('drop-out') once the young adult moves out of paediatric care. Non-attendance and sub-optimal medical self-management can lead to serious and expensive medical complications. In a pilot study, adolescents suggested the use of e-technology to become more involved in the transition process. The investigators have designed and developed the YESS! game, a tool to help improve medical self-management in adolescents with chronic endocrine disorders. The hypothesis is that adolescents playing the YESS! game will show a larger increase in self-management score during the first year of transition and will have a lower drop-out rate at the adult endocrine outpatient clinic (OPC), compared to adolescents who do not play the game.

Read the detailed description

Rationale: Transition from paediatric to adult endocrinology is a challenge for adolescents, families and doctors. Up to 25% of young adults with chronic endocrine disorders are lost to follow-up ('drop-out') once the young adult moves out of paediatric care. Non-attendance and sub-optimal medical self-management can lead to serious and expensive medical complications. In a pilot study, adolescents suggested the use of e-technology to become more involved in the transition process. The investigators have designed and developed the YESS! game, a tool to help improve medical self-management in adolescents with chronic endocrine disorders. The hypothesis is that adolescents playing the YESS! game will show a larger increase in self-management score during the first year of transition and will have a lower drop-out rate at the adult endocrine outpatient clinic (OPC), compared to adolescents who do not play the game.

Objective: 1.To improve medical self-management. 2.To prevent drop-out from the adult outpatient clinic. Study design: multicentre randomized controlled trial Study population: 160 transition patients from 15 to 20 years old from the participating countries Spain, The United Kingdom, Belgium and the Netherlands. Patients are diagnosed with a chronic endocrine disorder. Intervention: The study consists of 4 study arms: receiving the YESS! game and toolkit (group YT), receiving the control game and toolkit (group GT), receiving the toolkit only (group T) and receiving regular transition care (group O). Every group will receive regular transition care. The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management. Main study parameters: Primary outcome: the Self-management and Transition to Adulthood with Rx (=treatment) (STARx) questionnaire score 12 months after inclusion in group YT compared to group O. Secondary outcome: the STARx questionnaire score 6 months after inclusion in group YT compared to the other study groups, the STARx questionnaire score 12 months after inclusion in group YT compared to group GT and T and the drop-out rate to the adult outpatient clinic in the first year after the last visit to the paediatric endocrinologist (i.e. one year after the moment of transfer) in group YT compared to groups GT, T and O.

Nature and extent of the burden and risks associated with participation: The participants are not exposed to any risks. The YESS! and the control game are safe apps played on a mobile phone or tablet. The burden consists of filling out the STARx questionnaires and playing the YESS! or control game. The questionnaires will be filled out online at home at the start of the study and after 6 and 12 months. Every 6 months the subject has an appointment at the outpatient clinic. The participant can play the YESS! game for a maximum of 15 minutes a day to prevent game addiction. The control game could be played for an unlimited amount of time, but will unlikely cause game addiction since the game is not considered challenging and exciting enough.

02

Conditions studied

  • Congenital Adrenal Hyperplasia
  • Hypogonadotropic Hypogonadism
  • Growth Hormone Deficiency
  • Combined Pituitary Hormone Deficiency
  • Turner Syndrome
  • Klinefelter Syndrome
  • Addison's Disease
  • Androgen Insensitivity Syndrome
  • Thyroid Dysgenesis

Keywords

  • Serious game
  • Endocrinology
  • Transition
03

Who can participate

Ages eligible
15 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 15 to 20 years old.
  • Diagnosed with congenital adrenal hyperplasia, hypogonadotropic hypogonadism, Turner syndrome, Klinefelter syndrome, growth hormone deficiency, combined pituitary hormone deficiency, Androgen insensitivity syndrome, thyroid dysgenesis or Addison's disease

Exclusion criteria

Exclusion Criteria:

  • Lack of a mobile phone or tablet.
  • Intellectual disability or language barrier leading to inability to use the YESS! game or the control game.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    Group YT

    Group receives YESS! game and transition-toolkit

    Device: YESS! game · Other: Transition-toolkit

  • Experimental
    Group GT

    Group receives control game and transition-toolkit

    Device: Snake '97 · Other: Transition-toolkit

  • Experimental
    Group T

    Group receives transition-toolkit

    Other: Transition-toolkit

  • No intervention
    Group O

    Group receives usual transition care

Interventions

  • DeviceYESS! game

    The YESS! game is a real-life game for smartphone or tablet in which the player has to solve a mystery. The adolescent plays an active role in the course of the story. This results in an interactive experience. During the game, the adolescent is challenged with regard to self-management and responsible behaviour in general life, with parallels to medical selfmanagement and responsible behaviour. The adolescent has to decide at several different moments whether to take action or not, whether to accept help or not and whether to share (fictive) confidential information or not. Other aspects that are covered are 'taking responsibility' and 'being on time'. The choices the adolescent makes throughout the game are registered in a coded manner, for later analysis. The game is available in Dutch, English and Spanish.

  • DeviceSnake '97

    Snake '97 is a game for smartphone or tablet which is free and can be downloaded in the App Store. The game is a remake of the original snake on the mobile phone in 1997 in which the player moves the snake around and makes the snake 'consume food' (little dots) which causes the snake to grow longer. The goal is to make the snake as large as possible. The game has 12 difficulty levels.

    Also known as: control game

  • OtherTransition-toolkit

    The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management.

05

What researchers measure

Primary outcomes

  1. Medical self-management group YT compared to group O @12months

    The difference in Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score from baseline after 12 months in participants receiving the YESS! game and toolkit (group YT) compared to participants receiving regular care (group O).

    Time frame: 12 months

Secondary outcomes

  1. Medical self-management group YT compared to group GT and -T @12months

    The difference in Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score from baseline after 12 months in participants receiving the YESS! game and toolkit (group YT) compared to participants receiving the control game and toolkit (group GT) and participants receiving the toolkit only (group T). Transition to Adulthood with Rx (treatment) (STARx) questionnaire score in group YT compared to group GT and group T after 12 months.

    Time frame: 12 months

  2. Medical self-management in group YT compared to group GT, -T and -O @6months

    The difference in Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score from baseline after 6 months in participants receiving the YESS! game and toolkit (group YT) compared to participants receiving the control game and toolkit (group GT), participants receiving the toolkit only (group T) and participants receiving regular care (group O).

    Time frame: 6 months

  3. Drop-out rate adult outpatient clinic

    The difference in the drop-out rate to the outpatient clinic in group YT compared to group GT, group T and group O during the first year after the last visit to the paediatric endocrinologist (i.e. one year after the moment of transfer, t=24 m).

    Time frame: 12 months

06

Study locations

7 sites
  • Ghent University Hospital
    Ghent, 9000, Belgium
  • Erasmus Medical Center
    Rotterdam, Zuid-Holland 3015 GD, Netherlands
    • Laura CG de Graaff, MD, PhD · Contact · l.degraaff@erasmusmc.nl · +31618843010
    • Sabine E Hannema · Sub investigator
  • Hospital Infantil Universitario Niño Jesús
    Madrid, 28009, Spain
  • Queen Elizabeth University Hospital
    Glasgow, G51 4TF, United Kingdom
  • Royal Hospital for Children
    Glasgow, G51 4TF, United Kingdom
  • The Royal London Hospital (Barts Health NHS Trust)
    London, E1 1BB, United Kingdom
  • University College London Hospital (UCL Institute of Child Health)
    London, NW1 2PG, United Kingdom
07

References and documents

Individual participant data

Plan to share: Yes — The IPD has not been finalized yet. The investigators intent to share the full anonymized dataset, study protocol and statistical analysis plan upon request after publication of the results. Informed consent forms will not be shared."

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04252001
Lead sponsor
dr. Laura C. G. de Graaff-Herder
Responsible party
dr. Laura C. G. de Graaff-Herder (Principal Investigator, Erasmus Medical Center) — Sponsor-investigator
First posted
Feb 5, 2020
Start date
Dec 1, 2024 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Sep 7, 2023

Study contacts

Laura CG de Graaff, MD PhD
principal investigator · Erasmus Medical Centre

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion